Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

PET/CT allows stratification of responders to neoadjuvant chemotherapy for high-grade sarcoma: a prospective study.

Tateishi U, Kawai A, Chuman H, Nakatani F, Beppu Y, Seki K, Miyake M, Terauchi T, Moriyama N, Kim EE.

Clin Nucl Med. 2011 Jul;36(7):526-32. doi: 10.1097/RLU.0b013e3182175856.

PMID:
21637052
[PubMed - indexed for MEDLINE]
2.

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.

Cheebsumon P, Velasquez LM, Hoekstra CJ, Hayes W, Kloet RW, Hoetjes NJ, Smit EF, Hoekstra OS, Lammertsma AA, Boellaard R.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):832-42. doi: 10.1007/s00259-010-1705-9. Epub 2011 Jan 6.

PMID:
21210109
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.

Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M, Becker K, Schuster T, Essler M, Wieder HA, Friess H, Ziegler SI, Schwaiger M, Krause BJ.

Mol Imaging Biol. 2011 Oct;13(5):1011-9. doi: 10.1007/s11307-010-0383-0.

PMID:
20936364
[PubMed - indexed for MEDLINE]
4.

Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.

Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Mechtersheimer G, Schmitt T, Lehner B, Haberkorn U, Stroebel P, Kasper B.

J Nucl Med. 2010 Apr;51(4):551-8. doi: 10.2967/jnumed.109.070862. Erratum in: J Nucl Med. 2012 Oct;53(10):1658.

PMID:
20351350
[PubMed - indexed for MEDLINE]
Free Article
5.

Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.

Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA.

J Surg Oncol. 2010 Mar 15;101(4):327-33. doi: 10.1002/jso.21481. Review.

PMID:
20187067
[PubMed - indexed for MEDLINE]
6.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy.

Viglianti BL, Lora-Michiels M, Poulson JM, Lan L, Yu D, Sanders L, Craciunescu O, Vujaskovic Z, Thrall DE, Macfall J, Charles CH, Wong T, Dewhirst MW.

Clin Cancer Res. 2009 Aug 1;15(15):4993-5001. doi: 10.1158/1078-0432.CCR-08-2222. Epub 2009 Jul 21. Erratum in: Clin Cancer Res. 2009 Sep 1;15(17):5601. Yu, Dahio [corrected to Yu, Daohai].

PMID:
19622579
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.

Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D, Chow K, Evilevitch V, Eckardt JJ, Phelps ME, Weber WA, Eilber FC.

Clin Cancer Res. 2009 Apr 15;15(8):2856-63. doi: 10.1158/1078-0432.CCR-08-2537. Epub 2009 Apr 7.

PMID:
19351756
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.

Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, Weber WA.

J Nucl Med. 2008 Jul;49(7):1038-46. doi: 10.2967/jnumed.107.050187. Epub 2008 Jun 13.

PMID:
18552153
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

Strobel K, Dummer R, Steinert HC, Conzett KB, Schad K, Lago MP, Soyka JD, Veit-Haibach P, Seifert B, Kalff V.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1786-95. doi: 10.1007/s00259-008-0806-1. Epub 2008 May 6.

PMID:
18458901
[PubMed - indexed for MEDLINE]
10.

Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.

Dudeck O, Zeile M, Pink D, Pech M, Tunn PU, Reichardt P, Ludwig WD, Hamm B.

J Magn Reson Imaging. 2008 May;27(5):1109-13. doi: 10.1002/jmri.21358.

PMID:
18425832
[PubMed - indexed for MEDLINE]
11.

Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.

Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC.

Clin Cancer Res. 2008 Feb 1;14(3):715-20. doi: 10.1158/1078-0432.CCR-07-1762.

PMID:
18245531
[PubMed - indexed for MEDLINE]
Free Article
12.

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, Bredenkamp R, Höfler H, Fink U, Peschel C, Schwaiger M, Siewert JR.

Lancet Oncol. 2007 Sep;8(9):797-805.

PMID:
17693134
[PubMed - indexed for MEDLINE]
13.

Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

J Clin Oncol. 2007 Jul 20;25(21):3144-50.

PMID:
17634494
[PubMed - indexed for MEDLINE]
Free Article
14.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D; National Cancer Institute.

J Nucl Med. 2006 Jun;47(6):1059-66. No abstract available.

PMID:
16741317
[PubMed - indexed for MEDLINE]
Free Article
15.

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber WA, Werner M, Graeff H, Schwaiger M, Kuhn W.

J Clin Oncol. 2005 Oct 20;23(30):7445-53. Epub 2005 Sep 12. Erratum in: J Clin Oncol. 2005 Dec 20;23(36):9445.

PMID:
16157939
[PubMed - indexed for MEDLINE]
Free Article
16.

Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.

Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J.

J Nucl Med. 2005 Apr;46(4):603-7.

PMID:
15809482
[PubMed - indexed for MEDLINE]
Free Article
17.

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU 3rd, Eary JF.

Cancer. 2005 Jan 15;103(2):339-48.

PMID:
15578712
[PubMed - indexed for MEDLINE]
Free Article
18.

Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.

Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S.

J Am Coll Surg. 2004 Jul;199(1):1-7.

PMID:
15217621
[PubMed - indexed for MEDLINE]
19.

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.

Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J.

J Nucl Med. 2004 May;45(5):797-801.

PMID:
15136629
[PubMed - indexed for MEDLINE]
Free Article
20.

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.

Wieder HA, Brücher BL, Zimmermann F, Becker K, Lordick F, Beer A, Schwaiger M, Fink U, Siewert JR, Stein HJ, Weber WA.

J Clin Oncol. 2004 Mar 1;22(5):900-8.

PMID:
14990646
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk